Globus Medical Inc (GMED) 24.79 $GMED
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Globus Medical, Inc. Stockholders
Business Wire - Fri Apr 24, 6:11PM CDT
Kirby McInerney LLP is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company"
(NYSE:GMED) concerning the Company's and its officers' possible violations of federal securities laws. Kirby McInerney LLP is preparing a class action to recover damages on behalf of injured Globus shareholders.
GMED: 24.79 (+0.15)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
ACCESSWIRE - Fri Apr 24, 4:25PM CDT
NEW YORK, NY / ACCESSWIRE / April 24, 2015 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company" (NYSE: GMED). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
GMED: 24.79 (+0.15)
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by The Law Offices of Howard G. Smith
Business Wire - Fri Apr 24, 9:30AM CDT
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company" (NYSE:GMED) concerning the Company's and its officers' possible violations of federal securities laws.
GMED: 24.79 (+0.15)
North American Orthobiologics (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015-2019
M2 - Fri Apr 24, 9:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rkbq8c/north_american) has announced the addition of the "North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019" report to their offering. The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market. The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market. In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market. The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.). For more information visit http://www.researchandmarkets.com/research/rk...h_american
MDT: 77.61 (-0.89), GMED: 24.79 (+0.15), EXAC: 24.40 (+0.15), SYK: 96.90 (-0.28)
Globus Medical elects Daniel Scavilla as SVP & CFO
M2 - Fri Apr 24, 5:43AM CDT
Musculoskeletal implant manufacturer Globus Medical (NYSE:GMED) revealed on Thursday the addition of Daniel T Scavilla as its senior vice president and chief financial officer with effect from 4 May 2015.
JNJ: 101.08 (+0.62), GMED: 24.79 (+0.15)
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Thu Apr 23, 5:20PM CDT
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company" (NYSE: GMED) concerning the Company's and its officers' possible violations of federal securities laws. Glancy Binkow & Goldberg is preparing a class action to recover damages on behalf of injured Globus shareholders.
GMED: 24.79 (+0.15)
New finance chief at Globus Med
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 4:02PM CDT
GMED: 24.79 (+0.15)
Globus Medical Appoints Daniel Scavilla as Senior Vice President and CFO
Business Wire - Thu Apr 23, 3:54PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Daniel T. Scavilla as its Senior Vice President and Chief Financial Officer effective May 4, 2015.
JNJ: 101.08 (+0.62), GMED: 24.79 (+0.15)
Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019
M2 - Tue Apr 21, 3:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mk33m/orthopedics) has announced the addition of the "Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019" report to their offering. Global Orthopedics (Devices and Material) market is estimated to reach US$57.2 billion by 2017. Devices types; Joints (Repair & Replacement) Industry market is worth US$40.2 billion by 2017, growing at a CAGR of 8.9% for the analysis period 2013-2019 respectively. The Americas region accounts for highest percentage approximately 56.6% (2016) of global share while Europe follows next with nearly 19.7% (2019) of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.4% driving a market value of US$4.7 billion by 2016. By Material types; Orthopedics Biomaterials accounts for 48.3% of the market share and the rest is anticipated for Orthopedic Braces & Splints and Orthopedic Accessories. The report Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019' reviews the latest trends in orthopedics devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on: - Emerging Market Trends - Advancements in the Technological Space - Market Demand of The Segments (By-Region) - Key Growth Areas and Market Size - Region-Wise Demand Factor - Key Competitors Edge - Investment Strategies Companies Mentioned: Partial List for Each region The Americas - Aesculap, Inc. - Amedica Corp. (Usa) - Arthrocare Corporation (Usa) - Biomet, Inc. (Usa) - Conmed Corp (Usa) - Corin Group Plc (Usa) - Depuy Synthess, Inc. (Usa) - Donjoy, Inc. (Usa) - Exactech, Inc. (Usa) - Globus Medical, Inc. (Usa) Europe - Aap Implantate Ag (Germany) - Metoxit Ag (France) - Arthro Kinetics Plc (Germany) - Biedermann Motech Gmbh & Co Kg (Germany) - Biotechni (France) - Dot Gmbh (Germany) - Eska Orthodynamics Gmbh (Germany) - Gruppo Bioimpianti S.R.L. (Italy) - Inion Oy (Finland) - Lima-Lto Medical Systems (Italy) - Mathys Ltd. Bettlach (Switzerland) - Medacta International Sa (Switzerland) - Memometal Technologies (United Kingdom) - Metoxit Ag (France) Asia-Pacific - Denyers International (Australia) - Mesoblast Limited (Australia) - Orthocare Pty Ltd (Australia) - Austofix Group Ltd (Australia) - Trauson Medical Instrument Co., Ltd (China) - Wuhan Dragonbio Orthopedic Products Co., Ltd. (China) - Canwell Medical Ltd (China) - Suzhou Ortho Instrument Co., Ltd. (China) - M J Surgical (India) Rest Of World - Hipokrat Inc. (Turkey) - Onur Medikal Ltd. (Turkey) For more information visit http://www.researchandmarkets.com/research/3m...rthopedics
GMED: 24.79 (+0.15), MDSY: 2.50 (-0.06), EXAC: 24.40 (+0.15), AMDA: 0.27 (-0.01)
Globus Medical Schedules First Quarter 2015 Earnings Release and Conference Call
Business Wire - Mon Apr 20, 5:08PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2015 after the market close on Tuesday, May 5, 2015. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 24.79 (+0.15)
My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT
ZMH: 118.76 (+0.19), SIRO: 94.43 (+0.13), ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MASI: 34.83 (-0.07), IRIX: 10.02 (+0.19), ALGN: 59.18 (+3.17), CYNO: 33.89 (+0.66), GB: 55.62 (-0.35), EW: 138.33 (-3.59), ANIK: 38.35 (-0.32), ERB: 2.89 (+0.07), BABY: 42.15 (-0.01), GMED: 24.79 (+0.15), BAX: 71.14 (-0.37), STJ: 73.47 (-0.54), INGN: 37.13 (+0.11)
Insider Trading Alert - WLFC, GMED And PROV Traded By Insiders
at The Street - Mon Mar 23, 11:33AM CDT
Stocks with insider trader activity include WLFC, GMED and PROV
PROV: 16.39 (+0.14), GMED: 24.79 (+0.15), WLFC: 18.25 (-0.05)
Global Orthopedic Device (Hip, Knee, Spine, Extremities and Trauma Devices) Market 2015
M2 - Mon Mar 23, 7:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/83cb32/global_orthopedic) has announced the addition of the "Global Orthopedic Device Market (Hip, Knee, Spine, Extremities and Trauma Devices)" report to their offering. Worldwide, millions of dollars are spent annually on orthopedic devices. Demand for innovative product designs and the trend toward cost effective solutions drive the development of orthopedic device technology. The market faces challenges, though, due to issues of economics, demographics, technology and international opportunities. Global Orthopedic Device Market outlines the positive and negative influences affecting the orthopedic device market, especially seen in the reconstructive portion of the market but also in the trauma and spine portions as well. All market data pertain to the world market at the manufacturers' level. The base year for data was 2014. Historical data was provided for the years 2012, 2013 and 2014, with forecast data provided for 2015 through 2019. Compound annual growth rates (CAGRs) are provided for 2012-2014, 2014-2019, and 2012-2019 periods for each region and/or segment covered. Competitive analysis is provided for the year 2014. The forecasted market analysis for 2014-2019 is largely based on demographic trends, new developments, innovative technology and global expansion. The report's geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, China, Brazil, India and Japan. A market summary includes market analysis by product and region and a competitive analysis of leading providers. There are a number of issues and trends affecting this market, influencing its move into the future. Global Orthopedic Device Market discusses these: - Mergers and acquisitions - Community hospital involvement in trauma - Smart implants - Biologic putty - Biofilm formation - Generic orthopedic devices Corporate Profiles are: - Acumed - Advanced Orthopedic - Alphatec Spine - Arthrex - Biomet - Bioretec - Conmed - DePuy Synthes - DIGIMED Ortho - DJO Global - Emerge Medical - Eactech - Globus Medical - Hand Biomechanics - Integra Life Sciences - Intelligent Implant System - Osteomed - Rigid fx Corporation - RTI Surgical - Semprus Biosciences - Skeletal Dynamics - Small Bone Innovations - Smith & Nephew - Stryker - Suspension Orthopaedics - Tornier - TriMed - Vilex - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/83...orthopedic
SNN: 35.76 (+0.44), GMED: 24.79 (+0.15)
Insider Weekends - March 20, 2015
Asif Suria - at Seeking Alpha - Mon Mar 23, 1:34AM CDT
Welcome to edition 248 of Insider Weekends. Insider buying more than doubled last week, with insiders buying $148.24 million of stock, compared to $73.39 million in the week prior. Selling also increased, with insiders selling $1.51 billion of stock...
NOW: 76.09 (-0.79), DRII: 33.98 (+0.03), EVHC: 39.58 (+0.05), GMED: 24.79 (+0.15), FIVN: 5.71 (-0.13), MHK: 179.26 (+0.72), HTH: 19.57 (-0.08), PNC: 91.00 (-0.40), TWTR: 50.82 (-0.59), TCO: 73.65 (+0.55)
InsiderInsights.com Daily Round Up 3/20/15: DRRX, RWC, GEF.B, MRD
InsiderInsights - at Seeking Alpha - Sat Mar 21, 2:29AM CDT
NPBC: 10.54 (-0.16), HCOM: 26.37 (-0.03), DRII: 33.98 (+0.03), LGIH: 17.42 (+0.33), MRD: 19.33 (+0.12), STKL: 10.56 (-0.32), DRRX: 2.11 (-0.46), GOOG: 565.06 (+18.06), WSTC: 32.20 (-0.01), NLY: 10.25 (-0.01), PDVW: 52.96 (+2.28), GMED: 24.79 (+0.15), MHK: 179.26 (+0.72), NERV: 5.74 (+0.15), JAZZ: 189.42 (+0.33), RWC: 6.39 (+0.04), GOOGL: 573.66 (+16.20), ROST: 104.38 (-0.13)
The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Tue Mar 17, 6:56AM CDT
ELLI: 57.75 (+0.69), JCOM: 71.05 (+0.03), CAH: 91.38 (-0.12), CIEN: 22.17 (+0.48), AET: 108.82 (-0.08), ANAC: 64.49 (-2.10), CSL: 99.55 (+0.47), HSIC: 142.54 (+0.70), CAVM: 65.63 (-4.51), HAS: 71.61 (-0.10), MCHP: 47.33 (-1.24), COLM: 62.84 (+0.73), DEPO: 27.65 (+0.36), HRL: 54.85 (-0.03), COO: 181.75 (-1.24), DYAX: 27.44 (-0.85), LVLT: 54.67 (+0.05), CBRL: 142.08 (+0.67), AZO: 702.00 (-0.33), EQIX: 246.07 (-0.86), KNX: 31.45 (-0.14), HAE: 43.35 (+0.74), EL: 82.26 (-0.19), FSL: 38.86 (-1.12), CCK: 55.29 (+0.45), BLL: 74.56 (+2.09), CDW: 38.87 (-0.15), ADBE: 76.54 (+0.02), AFFX: 12.44 (-0.16), AGN: 240.22 (+2.88), DPS: 78.86 (-0.09), INFA: 48.16 (+0.16), APH: 56.17 (-0.53), GEVA: 108.51 (+0.92), LII: 108.00 (+0.75), GMED: 24.79 (+0.15), BJRI: 49.52 (-3.92), DPZ: 113.96 (+4.73), HBI: 32.22 (-2.36), FL: 60.86 (+0.14), DLX: 67.37 (-0.17), ABT: 48.32 (-0.14), KR: 71.70 (+0.77), ABCO: 52.24 (+0.30), DIOD: 27.28 (-0.72), LEG: 44.31 (+0.21), DIS: 109.53 (+0.53), GLW: 22.52 (-0.27), MAR: 81.84 (+0.49), LEA: 115.08 (-0.97), DISH: 69.91 (+0.30), IMAX: 37.62 (+0.22), CNC: 73.67 (+1.13), CTAS: 82.13 (-0.18), CMCSA: 59.64 (+0.41), FLO: 22.31 (-0.20), BIG: 47.57 (-0.16), CRM: 67.83 (-0.64)
LDR Holding: An Excellent Play In The Non-Fusion Spine Market
Andy Batts - at Seeking Alpha - Tue Mar 10, 6:45AM CDT
LDRH: 36.92 (-0.14), GMED: 24.79 (+0.15), NUVA: 43.99 (+0.23)
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 8:40AM CST
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED), reported adjusted earnings per share ("EPS" of 30 cents in the fourth quarter of 2014, beating the Zacks Consensus Estimate by 4 cents.
GMED: 24.79 (+0.15), ABAX: 63.62 (+0.31), LMNX: 16.10 (-0.18), AFFX: 12.44 (-0.16)
Globus Medical's (GMED) CEO David Paul on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 10:33PM CST
GMED: 24.79 (+0.15)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 4:35PM CST
CXO: 125.84 (-0.64), CSGP: 199.49 (-1.23), HK: 1.57 (-0.04), GPOR: 48.74 (-0.75), BLDP: 2.18 (-0.03), PRSS: 3.98 (+0.10), EAC: 4.30 (+0.02), GXP: 26.87 (+0.21), DXCM: 69.43 (-1.13), LHCG: 36.06 (+1.33), STAA: 9.14 (+0.02), ESRT: 18.25 (+0.25), PGTI: 11.56 (-0.01), ORIG: 6.87 (-0.11), CWT: 24.73 (+0.47), MCHX: 4.49 (-0.09), RGR: 56.18 (-0.03), CLUB: 6.41 (-0.03), MMLP: 36.55 (-0.41), AR: 42.56 (+0.26), IL: 10.15 (+0.10), FOE: 12.62 (unch), ARI: 17.28 (+0.07), ANIK: 38.35 (-0.32), FARO: 43.44 (-1.22), BWC: 32.32 (-0.17), ESV: 24.04 (-0.23), MELI: 137.48 (-1.49), EPAM: 66.61 (-0.95), OAS: 16.26 (-0.20), AWR: 39.92 (+0.30), BMRN: 120.28 (-2.67), SFM: 33.92 (+0.02), ELGX: 17.08 (-0.02), AEGN: 18.99 (+0.34), AREX: 7.98 (-0.36), MDVN: 131.01 (-1.50), AGO: 27.16 (+0.18), RIG: 16.40 (-0.57), GMED: 24.79 (+0.15), DRYS: 0.73 (+0.02), AMSG: 65.33 (+0.04), LGCY: 13.21 (-0.59), CHDN: 114.04 (-0.12), KW: 25.81 (+0.24), PVA: 6.67 (-0.34), PLKI: 59.22 (+2.06), RIGP: 14.71 (-0.21), LB: 91.20 (-0.45), CLVS: 92.03 (+1.78), SBY: 15.94 (+0.01), CEMP: 39.02 (+0.23), CHMT: 30.56 (+0.12), AVGO: 119.50 (-4.57), CRM: 67.83 (-0.64), EHTH: 13.50 (+2.06)
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Globus Medical, Inc. Stockholders
Business Wire - Fri Apr 24, 6:11PM CDT
Kirby McInerney LLP is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company"
(NYSE:GMED) concerning the Company's and its officers' possible violations of federal securities laws. Kirby McInerney LLP is preparing a class action to recover damages on behalf of injured Globus shareholders. GMED: 24.79 (+0.15)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
ACCESSWIRE - Fri Apr 24, 4:25PM CDT
NEW YORK, NY / ACCESSWIRE / April 24, 2015 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company"
(NYSE: GMED). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. GMED: 24.79 (+0.15)
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by The Law Offices of Howard G. Smith
Business Wire - Fri Apr 24, 9:30AM CDT
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company"
(NYSE:GMED) concerning the Company's and its officers' possible violations of federal securities laws. GMED: 24.79 (+0.15)
North American Orthobiologics (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation) Market 2015-2019
M2 - Fri Apr 24, 9:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rkbq8c/north_american) has announced the addition of the "North American Orthobiologics Market by Type (Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy, Viscosupplementation), by End-User (Hospitals, Point-of-Care Testing) - Analysis and Forecast to 2019" report to their offering. The North America orthobiologics market is estimated to grow at a CAGR of 7.7% from 2014 to 2019. North America is the highest contributor of the global orthobiologics market. The high demand from end-user segment such as hospitals, point of care testing boosts the market growth for orthobiologics market. The increasing expansion and product portfolio expansion has also been driving the growth in the North America orthobiologics market. In April 2011; Tornier, Inc. launched BioFiber Surgical mesh, which is used in tendon repair. This product is a three dimensional structure that enhances healing process of bones. It helps to enhance the product portfolio of the company and also complements the other biologic products that the company offers. The report has profiled the leading players of this market along with the developments (new product launches and partnerships, and joint ventures) by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the North America orthobiologics market. The key players in the North America orthobiologics market are Biomet, Inc. (U.S.), Medtronic, Plc. (U.S.), Integra Life Sciences Corporation (U.S.)., Stryker Corporation (U.S.), Zimmer, Inc. (U.S.), Tornier, Inc. (Netherlands), Nuvasive, Inc. (U.S.), Exactech, Inc. (U.S.), Globus Medical, Inc. (U.S.), and Wright Medical Technology, Inc. (U.S.). For more information visit http://www.researchandmarkets.com/research/rk...h_american
MDT: 77.61 (-0.89), GMED: 24.79 (+0.15), EXAC: 24.40 (+0.15), SYK: 96.90 (-0.28)
Globus Medical elects Daniel Scavilla as SVP & CFO
M2 - Fri Apr 24, 5:43AM CDT
Musculoskeletal implant manufacturer Globus Medical (NYSE:GMED) revealed on Thursday the addition of Daniel T Scavilla as its senior vice president and chief financial officer with effect from 4 May 2015.
JNJ: 101.08 (+0.62), GMED: 24.79 (+0.15)
GMED INVESTOR ALERT: Investigation of Globus Medical, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Thu Apr 23, 5:20PM CDT
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company"
(NYSE: GMED) concerning the Company's and its officers' possible violations of federal securities laws. Glancy Binkow & Goldberg is preparing a class action to recover damages on behalf of injured Globus shareholders. GMED: 24.79 (+0.15)
New finance chief at Globus Med
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 4:02PM CDT
GMED: 24.79 (+0.15)
Globus Medical Appoints Daniel Scavilla as Senior Vice President and CFO
Business Wire - Thu Apr 23, 3:54PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced it appointed Daniel T. Scavilla as its Senior Vice President and Chief Financial Officer effective May 4, 2015.
JNJ: 101.08 (+0.62), GMED: 24.79 (+0.15)
Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019
M2 - Tue Apr 21, 3:42AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3mk33m/orthopedics) has announced the addition of the "Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019" report to their offering. Global Orthopedics (Devices and Material) market is estimated to reach US$57.2 billion by 2017. Devices types; Joints (Repair & Replacement) Industry market is worth US$40.2 billion by 2017, growing at a CAGR of 8.9% for the analysis period 2013-2019 respectively. The Americas region accounts for highest percentage approximately 56.6% (2016) of global share while Europe follows next with nearly 19.7% (2019) of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.4% driving a market value of US$4.7 billion by 2016. By Material types; Orthopedics Biomaterials accounts for 48.3% of the market share and the rest is anticipated for Orthopedic Braces & Splints and Orthopedic Accessories. The report Orthopedics (Devices & Materials) - Global Trends, Estimates and Forecasts, 2013-2019' reviews the latest trends in orthopedics devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on: - Emerging Market Trends - Advancements in the Technological Space - Market Demand of The Segments (By-Region) - Key Growth Areas and Market Size - Region-Wise Demand Factor - Key Competitors Edge - Investment Strategies Companies Mentioned: Partial List for Each region The Americas - Aesculap, Inc. - Amedica Corp. (Usa) - Arthrocare Corporation (Usa) - Biomet, Inc. (Usa) - Conmed Corp (Usa) - Corin Group Plc (Usa) - Depuy Synthess, Inc. (Usa) - Donjoy, Inc. (Usa) - Exactech, Inc. (Usa) - Globus Medical, Inc. (Usa) Europe - Aap Implantate Ag (Germany) - Metoxit Ag (France) - Arthro Kinetics Plc (Germany) - Biedermann Motech Gmbh & Co Kg (Germany) - Biotechni (France) - Dot Gmbh (Germany) - Eska Orthodynamics Gmbh (Germany) - Gruppo Bioimpianti S.R.L. (Italy) - Inion Oy (Finland) - Lima-Lto Medical Systems (Italy) - Mathys Ltd. Bettlach (Switzerland) - Medacta International Sa (Switzerland) - Memometal Technologies (United Kingdom) - Metoxit Ag (France) Asia-Pacific - Denyers International (Australia) - Mesoblast Limited (Australia) - Orthocare Pty Ltd (Australia) - Austofix Group Ltd (Australia) - Trauson Medical Instrument Co., Ltd (China) - Wuhan Dragonbio Orthopedic Products Co., Ltd. (China) - Canwell Medical Ltd (China) - Suzhou Ortho Instrument Co., Ltd. (China) - M J Surgical (India) Rest Of World - Hipokrat Inc. (Turkey) - Onur Medikal Ltd. (Turkey) For more information visit http://www.researchandmarkets.com/research/3m...rthopedics
GMED: 24.79 (+0.15), MDSY: 2.50 (-0.06), EXAC: 24.40 (+0.15), AMDA: 0.27 (-0.01)
Globus Medical Schedules First Quarter 2015 Earnings Release and Conference Call
Business Wire - Mon Apr 20, 5:08PM CDT
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2015 after the market close on Tuesday, May 5, 2015. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
GMED: 24.79 (+0.15)
My Top Health Care Equipment And Supplies Stocks For 2015
Stan Stafford - at Seeking Alpha - Fri Apr 10, 12:52PM CDT
ZMH: 118.76 (+0.19), SIRO: 94.43 (+0.13), ABMD: 68.83 (-0.74), BDX: 144.33 (-0.02), MASI: 34.83 (-0.07), IRIX: 10.02 (+0.19), ALGN: 59.18 (+3.17), CYNO: 33.89 (+0.66), GB: 55.62 (-0.35), EW: 138.33 (-3.59), ANIK: 38.35 (-0.32), ERB: 2.89 (+0.07), BABY: 42.15 (-0.01), GMED: 24.79 (+0.15), BAX: 71.14 (-0.37), STJ: 73.47 (-0.54), INGN: 37.13 (+0.11)
Insider Trading Alert - WLFC, GMED And PROV Traded By Insiders
at The Street - Mon Mar 23, 11:33AM CDT
Stocks with insider trader activity include WLFC, GMED and PROV
PROV: 16.39 (+0.14), GMED: 24.79 (+0.15), WLFC: 18.25 (-0.05)
Global Orthopedic Device (Hip, Knee, Spine, Extremities and Trauma Devices) Market 2015
M2 - Mon Mar 23, 7:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/83cb32/global_orthopedic) has announced the addition of the "Global Orthopedic Device Market (Hip, Knee, Spine, Extremities and Trauma Devices)" report to their offering. Worldwide, millions of dollars are spent annually on orthopedic devices. Demand for innovative product designs and the trend toward cost effective solutions drive the development of orthopedic device technology. The market faces challenges, though, due to issues of economics, demographics, technology and international opportunities. Global Orthopedic Device Market outlines the positive and negative influences affecting the orthopedic device market, especially seen in the reconstructive portion of the market but also in the trauma and spine portions as well. All market data pertain to the world market at the manufacturers' level. The base year for data was 2014. Historical data was provided for the years 2012, 2013 and 2014, with forecast data provided for 2015 through 2019. Compound annual growth rates (CAGRs) are provided for 2012-2014, 2014-2019, and 2012-2019 periods for each region and/or segment covered. Competitive analysis is provided for the year 2014. The forecasted market analysis for 2014-2019 is largely based on demographic trends, new developments, innovative technology and global expansion. The report's geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Information is presented as a worldwide overview, with special emphasis on the U.S., Europe, China, Brazil, India and Japan. A market summary includes market analysis by product and region and a competitive analysis of leading providers. There are a number of issues and trends affecting this market, influencing its move into the future. Global Orthopedic Device Market discusses these: - Mergers and acquisitions - Community hospital involvement in trauma - Smart implants - Biologic putty - Biofilm formation - Generic orthopedic devices Corporate Profiles are: - Acumed - Advanced Orthopedic - Alphatec Spine - Arthrex - Biomet - Bioretec - Conmed - DePuy Synthes - DIGIMED Ortho - DJO Global - Emerge Medical - Eactech - Globus Medical - Hand Biomechanics - Integra Life Sciences - Intelligent Implant System - Osteomed - Rigid fx Corporation - RTI Surgical - Semprus Biosciences - Skeletal Dynamics - Small Bone Innovations - Smith & Nephew - Stryker - Suspension Orthopaedics - Tornier - TriMed - Vilex - Wright Medical - Zimmer For more information visit http://www.researchandmarkets.com/research/83...orthopedic
SNN: 35.76 (+0.44), GMED: 24.79 (+0.15)
Insider Weekends - March 20, 2015
Asif Suria - at Seeking Alpha - Mon Mar 23, 1:34AM CDT
Welcome to edition 248 of Insider Weekends. Insider buying more than doubled last week, with insiders buying $148.24 million of stock, compared to $73.39 million in the week prior. Selling also increased, with insiders selling $1.51 billion of stock...
NOW: 76.09 (-0.79), DRII: 33.98 (+0.03), EVHC: 39.58 (+0.05), GMED: 24.79 (+0.15), FIVN: 5.71 (-0.13), MHK: 179.26 (+0.72), HTH: 19.57 (-0.08), PNC: 91.00 (-0.40), TWTR: 50.82 (-0.59), TCO: 73.65 (+0.55)
InsiderInsights.com Daily Round Up 3/20/15: DRRX, RWC, GEF.B, MRD
InsiderInsights - at Seeking Alpha - Sat Mar 21, 2:29AM CDT
NPBC: 10.54 (-0.16), HCOM: 26.37 (-0.03), DRII: 33.98 (+0.03), LGIH: 17.42 (+0.33), MRD: 19.33 (+0.12), STKL: 10.56 (-0.32), DRRX: 2.11 (-0.46), GOOG: 565.06 (+18.06), WSTC: 32.20 (-0.01), NLY: 10.25 (-0.01), PDVW: 52.96 (+2.28), GMED: 24.79 (+0.15), MHK: 179.26 (+0.72), NERV: 5.74 (+0.15), JAZZ: 189.42 (+0.33), RWC: 6.39 (+0.04), GOOGL: 573.66 (+16.20), ROST: 104.38 (-0.13)
The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Tue Mar 17, 6:56AM CDT
ELLI: 57.75 (+0.69), JCOM: 71.05 (+0.03), CAH: 91.38 (-0.12), CIEN: 22.17 (+0.48), AET: 108.82 (-0.08), ANAC: 64.49 (-2.10), CSL: 99.55 (+0.47), HSIC: 142.54 (+0.70), CAVM: 65.63 (-4.51), HAS: 71.61 (-0.10), MCHP: 47.33 (-1.24), COLM: 62.84 (+0.73), DEPO: 27.65 (+0.36), HRL: 54.85 (-0.03), COO: 181.75 (-1.24), DYAX: 27.44 (-0.85), LVLT: 54.67 (+0.05), CBRL: 142.08 (+0.67), AZO: 702.00 (-0.33), EQIX: 246.07 (-0.86), KNX: 31.45 (-0.14), HAE: 43.35 (+0.74), EL: 82.26 (-0.19), FSL: 38.86 (-1.12), CCK: 55.29 (+0.45), BLL: 74.56 (+2.09), CDW: 38.87 (-0.15), ADBE: 76.54 (+0.02), AFFX: 12.44 (-0.16), AGN: 240.22 (+2.88), DPS: 78.86 (-0.09), INFA: 48.16 (+0.16), APH: 56.17 (-0.53), GEVA: 108.51 (+0.92), LII: 108.00 (+0.75), GMED: 24.79 (+0.15), BJRI: 49.52 (-3.92), DPZ: 113.96 (+4.73), HBI: 32.22 (-2.36), FL: 60.86 (+0.14), DLX: 67.37 (-0.17), ABT: 48.32 (-0.14), KR: 71.70 (+0.77), ABCO: 52.24 (+0.30), DIOD: 27.28 (-0.72), LEG: 44.31 (+0.21), DIS: 109.53 (+0.53), GLW: 22.52 (-0.27), MAR: 81.84 (+0.49), LEA: 115.08 (-0.97), DISH: 69.91 (+0.30), IMAX: 37.62 (+0.22), CNC: 73.67 (+1.13), CTAS: 82.13 (-0.18), CMCSA: 59.64 (+0.41), FLO: 22.31 (-0.20), BIG: 47.57 (-0.16), CRM: 67.83 (-0.64)
LDR Holding: An Excellent Play In The Non-Fusion Spine Market
Andy Batts - at Seeking Alpha - Tue Mar 10, 6:45AM CDT
LDRH: 36.92 (-0.14), GMED: 24.79 (+0.15), NUVA: 43.99 (+0.23)
Globus Medical (GMED) Beats on Q4 Earnings, Sales in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 8:40AM CST
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED), reported adjusted earnings per share ("EPS"
of 30 cents in the fourth quarter of 2014, beating the Zacks Consensus Estimate by 4 cents. GMED: 24.79 (+0.15), ABAX: 63.62 (+0.31), LMNX: 16.10 (-0.18), AFFX: 12.44 (-0.16)
Globus Medical's (GMED) CEO David Paul on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 10:33PM CST
GMED: 24.79 (+0.15)
Notable earnings after Wednesday's close
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 4:35PM CST
CXO: 125.84 (-0.64), CSGP: 199.49 (-1.23), HK: 1.57 (-0.04), GPOR: 48.74 (-0.75), BLDP: 2.18 (-0.03), PRSS: 3.98 (+0.10), EAC: 4.30 (+0.02), GXP: 26.87 (+0.21), DXCM: 69.43 (-1.13), LHCG: 36.06 (+1.33), STAA: 9.14 (+0.02), ESRT: 18.25 (+0.25), PGTI: 11.56 (-0.01), ORIG: 6.87 (-0.11), CWT: 24.73 (+0.47), MCHX: 4.49 (-0.09), RGR: 56.18 (-0.03), CLUB: 6.41 (-0.03), MMLP: 36.55 (-0.41), AR: 42.56 (+0.26), IL: 10.15 (+0.10), FOE: 12.62 (unch), ARI: 17.28 (+0.07), ANIK: 38.35 (-0.32), FARO: 43.44 (-1.22), BWC: 32.32 (-0.17), ESV: 24.04 (-0.23), MELI: 137.48 (-1.49), EPAM: 66.61 (-0.95), OAS: 16.26 (-0.20), AWR: 39.92 (+0.30), BMRN: 120.28 (-2.67), SFM: 33.92 (+0.02), ELGX: 17.08 (-0.02), AEGN: 18.99 (+0.34), AREX: 7.98 (-0.36), MDVN: 131.01 (-1.50), AGO: 27.16 (+0.18), RIG: 16.40 (-0.57), GMED: 24.79 (+0.15), DRYS: 0.73 (+0.02), AMSG: 65.33 (+0.04), LGCY: 13.21 (-0.59), CHDN: 114.04 (-0.12), KW: 25.81 (+0.24), PVA: 6.67 (-0.34), PLKI: 59.22 (+2.06), RIGP: 14.71 (-0.21), LB: 91.20 (-0.45), CLVS: 92.03 (+1.78), SBY: 15.94 (+0.01), CEMP: 39.02 (+0.23), CHMT: 30.56 (+0.12), AVGO: 119.50 (-4.57), CRM: 67.83 (-0.64), EHTH: 13.50 (+2.06)
